Endo Offers $175 A Share For Salix, Trumping Valeant

By | March 11, 2015

Scalper1 News

Endo International (ENDP) confirmed that it has made a bid of $175 share for Salix Pharmaceuticals (SLXP), after Valeant Pharmaceuticals (VRX) announced in late February it had reached a deal to buy Salix for $158 a share. Endo said it would offer cash and stock — reportedly 1.4607 Endo shares plus $45 in cash for each share of Salix,, which specializes in gastrointestinal drugs. Trading of Salix shares and Endo were halted pending Endo’s Scalper1 News

Scalper1 News